$10.84
-0.1-0.91%
Last update: Oct 5, 10:12 AM
$10.96
0.020.18%
Climb Bio Inc
CLYMNASDAQ
Climb Bio (CLYM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.30 | $-0.20 | $-0.15 |
| Actual | $-0.18 | $-0.20 | $-0.26 | $-0.19 |
| Surprise | +18.2% | +33.3% | -30.0% | -26.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.19 | $-0.20 | $-0.23 | $-0.25 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.18 | $-0.22 | 18.2 % |
| Q1 | May 7, 2026 | $-0.20 | $-0.30 | 33.3 % |
| Q4 | Mar 5, 2026 | $-0.26 | $-0.20 | -30.0 % |
| Q3 | Nov 6, 2025 | $-0.19 | $-0.15 | -26.7 % |
